Supplementary Figure S5 from Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047

Key Points

• Biomarker analysis reveals key CD8 characteristics in the tumor microenvironment, and highlights immune response dynamics.
• Important findings include detailed profiles of CD8 T cells in advancing melanoma, emphasizing immune interactions.
• Assessment of CD8 characterization focuses on tumor microenvironments and provides insights into patient responses to treatment.
• These results suggest potential pathways for enhancing immune therapies, pushing for further studies in advanced melanoma.